A Novel Cooling Vest to Protect Persons With SCI From Hyperthermia
Development of a Novel Cooling Vest to Prevent Heat-Induced Thermoregulatory Dysfunction in Persons With Spinal Cord Injury
1 other identifier
interventional
15
1 country
1
Brief Summary
Persons with higher levels of spinal cord injury (above the 6th thoracic vertebrae: Hi-SCI) are unable to maintain their core body temperature (Tcore) within the normal range (97.5-99.7 °F) when exposed to warm environments. Even limited exposure to warm temperatures can cause hyperthermia (Tcore 100.4°F) in Hi-SCI. Mild hyperthermia causes discomfort and impaired thinking, but if unchecked, can lead to permanent damage to the brain, multiple body organ failure, and death. Warm seasonal temperatures have an adverse effect on personal comfort and the ability to participate in daily social activities in persons with Hi-SCI. Interventions addressing this vulnerability to hyperthermia are limited. A self-regulating "smart" cooling vest designed for persons with Hi-SCI, that can effectively dissipate body heat, is a novel and promising strategy to address this problem. Once the current prototype is further developed and bench-tested, the investigators will test the vest in able-bodied participants for safety and comfort. The investigators will then test the vest in participants with Hi-SCI for efficacy. The aim for the cooling vest to minimize the expected increase of 1.1°F in Tcore by at least 50 percent and increase thermal comfort, during a controlled exposure to heat (95°F). If successful, the vest will provide a promising intervention to decrease the adverse impact of warm temperatures on comfort, quality of life, and participation in societal functions for Veterans with Hi-SCI during the warmer seasons.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Dec 2023
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
June 16, 2022
CompletedFirst Posted
Study publicly available on registry
July 1, 2022
CompletedStudy Start
First participant enrolled
December 18, 2023
CompletedPrimary Completion
Last participant's last visit for primary outcome
January 31, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
January 31, 2025
CompletedResults Posted
Study results publicly available
April 15, 2025
CompletedApril 30, 2025
April 1, 2025
1.1 years
June 16, 2022
March 26, 2025
April 14, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
Skin Temperature (Tsk) Change
Tsk will be monitored using TX-4 Skin Surface probes and Iso-Thermex Multichannel Thermometer (Columbus Instruments, Columbus, OH). Skin thermocouples will be taped to 12 sites on the trunk (chest/abdomen) of AB controls (6 on each side) and on 10 sites on the chest/abdomen (5 on each side) and 4 sites on the bilateral hands and feet (2 on each side) for a total of 14 sites on persons with Hi-SCI determine change and minimum skin temperatures beneath the cooling vest
Baseline (0 min) and end of thermal challenge (120 min) will be compared
Thermal Sensation (TS) Change
TS will be measured by a 9-point (+4 to -4) thermal sensation scale (+4 Very Hot. +3 Hot, +2 Warm, +1 Slightly Warm, 0 Neutral, -1 Slightly Cool, -2 Cool, -3 Cold, -4 Very Cold). During a thermal challenge, a subjective score of "0" (Neutral) would be preferred as it indicates thermoregulatory mechanisms are effective for the participant.
Baseline (0 min) and end of thermal challenge (120 min) will be compared
Secondary Outcomes (2)
Core Body Temperature (Tcore) Change
Baseline (0 min) and end of thermal challenge (120 min) will be compared in persons with Hi-SCI
Thermal Comfort (TC) Change
Baseline (0 min) and end of thermal challenge (120 min) will be compared in persons with Hi-SCI
Study Arms (3)
Arm 1: Cooling Vest
EXPERIMENTALPhase 1: After satisfying bench testing criteria, AB participants will wear the wet cooling vest at maximal settings for 2 hours in the seated position in a warm thermal chamber (35°C), to determine: (1) minimum skin temperatures beneath the cooling vest and (2) subjective thermal sensation of their skin beneath the cooling vest.
Arm 2: Cooling Vest
EXPERIMENTALPhase 2: Participants with Hi-SCI will wear the wet vest (experimental condition) in a warm thermal chamber (35°C) for up to 2 hours in the seated position, to determine: (1) change in Tcore and (2) perception of heat and thermal comfort.
Arm 3: No Vest
NO INTERVENTIONPhase 2: Participants with Hi-SCI will wear no vest (control condition) in a warm thermal chamber (35°C) for up to 2 hours in the seated position, to determine: (1) change in Tcore and (2) perception of heat and thermal comfort.
Interventions
A self-regulating cooling vest for persons with SCI that can utilize both conductive and evaporative methods to dissipate body heat as a proof-of-concept to prevent an excessive rise in Tcore and thermal discomfort during a controlled exposure to a warm environment. The vest is an article of clothing, is made of commercially-available "wicking" material, which once saturated with water, uses evaporation to dissipate heat. Channels embedded in the vest supply cooled water to keep the wet vest cool. The cooling capacity of the vest is regulated by a microprocessor which continuously receives feedback from the user's skin and core temperature. The vest is non-invasive and supplies no energy to the user.
Eligibility Criteria
You may qualify if:
- Spinal cord injury (SCI) \>1 year in duration
- Level of SCI C4-T2, ASIA Impairment Scale A \& B
- Gender and age-matched (±5 years) able-bodied (AB) controls
- Euhydration (participants will be instructed to avoid caffeine and alcohol, maintain normal salt and water intake and avoid strenuous exercise for 24 hours prior to study)
You may not qualify if:
- Known cardiovascular, kidney or untreated thyroid disease
- Traumatic brain injury (mod-severe)
- Diabetes mellitus
- Acute illness or infection
- Broken, inflamed, or otherwise fragile skin
- Pregnancy
- BMI \>30 kg/m2
- Smoking Participants with SCI only (secondary to telemetry capsule (CorTemp®) measurement of Tcore)
- Undergoing magnetic resonance imaging while the telemetry capsule is within the body (2-5 days)
- Cardiac pacemaker or other implanted electromedical device
- Known or suspected obstructive disease of the GI tract
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
James J. Peters VA Medical Center, Bronx, NY
The Bronx, New York, 10468-3904, United States
Related Links
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Results Point of Contact
- Title
- Dr. John Handrakis
- Organization
- Spinal Cord Damage research Center, James J. Peters VA Medical Center
Study Officials
- PRINCIPAL INVESTIGATOR
John Philip Handrakis, PT DPT EdD
James J. Peters Veterans Affairs Medical Center
Publication Agreements
- PI is Sponsor Employee
- Yes
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- DEVICE FEASIBILITY
- Intervention Model
- FACTORIAL
- Sponsor Type
- FED
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
June 16, 2022
First Posted
July 1, 2022
Study Start
December 18, 2023
Primary Completion
January 31, 2025
Study Completion
January 31, 2025
Last Updated
April 30, 2025
Results First Posted
April 15, 2025
Record last verified: 2025-04
Data Sharing
- IPD Sharing
- Will not share
A de-identified data set will be shared with the public. Age and SCI level along with all other 18 HIPAA identifiers will be withheld. This data will be shared under an agreement that does not allow re-identification of the data set.